Dupilumab Efficacy in Asthma Patients With FEV1 60–80% Predicted on Medium-Dose ICS: liberty asthma quest StudyAlberto Papi,Ian D. Pavord,J. Mark Fitzgerald,Jonathan Corren,Philip Bardin,Hae Sim Park,Megan S. Rice,Yamo Deniz,Paul Rowe,Heribert Staudinger,Nikhil Amin,Marcella Ruddy,Neil M.H. Graham,Ariel TeperEUROPEAN RESPIRATORY JOURNAL（2019）引用 1|浏览38暂无评分关键词Asthma - managementAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
